LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma

A. Sverrild, K. Baines, V. Backer, P. Gibson, C. Porsbjerg (Copenhagen, Denmark; Newcastle, Australia)

Source: International Congress 2014 – New technologies and biomarkers in lung disease
Session: New technologies and biomarkers in lung disease
Session type: Poster Discussion
Number: 1800
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Sverrild, K. Baines, V. Backer, P. Gibson, C. Porsbjerg (Copenhagen, Denmark; Newcastle, Australia). LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma. Eur Respir J 2014; 44: Suppl. 58, 1800

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015


Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

Airway inflammation in patients with different levels of asthma control
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013


Ration of IL1beta / IL1-receptor antagonist (RA) in alveolar macrophages of induced sputum of patients with asthma during long-term follow-up
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015


LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

Correlation between asthma control and serum levels of IL-33 in atopic asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

Activin-A BAL levels and Immunochemistry for activin A receptors in patients with asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Eosinophilic airway inflammation is associated with increased TLR2 and TLR4 expression in adult asthmatics
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014


Blockade of TSLP pathway alters asthma biomarkers
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014

Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014


Elevated GM-CSF in COPD may drive defective macrophage phenotype
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

The role of chemokine receptors in the aberrant migration of COPD neutrophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014

LATE-BREAKING ABSTRACT: BAFF: a self-perpetuating mechanism of B cell activation in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014

LATE-BREAKING ABSTRACT: p-STAT6 and PU.1 are involved in IL-9 production by Th9 cells during allergen-induced late phase airway inflammation in asthma patients
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

MicroRNA-146a and microRNA-155 expression in induced sputum of allergic asthmatics
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015

Impaired synthesis and transport of immunoglobulin A in severe asthma: Role of IL-13
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015


LATE-BREAKING ABSTRACT: Surfactant protein D is dysregulated in severe asthma
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014